Identify biomarkers to help predict patient clinical response.
The HuMark platform leverages data from mouse clinical trials (HuTrials™) and utilizes patient-derived xenograft models (HuPrime® and HuKemia®). This translational platform spans a range of capabilities and analyses, from tissue collection to data analysis, and helps validate antitumor effects against predicted human targets.